Wells Fargo’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-50,000
| Closed | -$60K | – | 6892 |
|
|
2019
Q1 | $60K | Sell |
50,000
-1,100
| -2% | -$96.2K | ﹤0.01% | 5281 |
|
|
2018
Q4 | $1.08M | Buy |
51,100
+900
| +2% | +$66.4K | ﹤0.01% | 3785 |
|
|
2018
Q3 | $288K | Buy |
50,200
+200
| +0.4% | +$17.7K | ﹤0.01% | 4799 |
|
|
2018
Q2 | $574K | Hold |
50,000
| – | – | ﹤0.01% | 4346 |
|
|
2018
Q1 | $421K | Buy |
+50,000
| New | +$4.8M | ﹤0.01% | 4525 |
|
|
2017
Q4 | – | Sell |
-24,200
| Closed | -$39K | – | 6794 |
|
|
2017
Q3 | $39K | Buy |
24,200
+1,200
| +5% | +$163K | ﹤0.01% | 5546 |
|
|
2017
Q2 | $161K | Sell |
23,000
-22,000
| -49% | -$2.7M | ﹤0.01% | 4916 |
|
|
2017
Q1 | $103K | Sell |
45,000
-5,000
| -10% | -$598K | ﹤0.01% | 5190 |
|
|
2016
Q4 | $3K | Hold |
50,000
| – | – | ﹤0.01% | 6074 |
|
|
2016
Q3 | $109K | Hold |
50,000
| – | – | ﹤0.01% | 4870 |
|
|
2016
Q2 | $282K | Buy |
+50,000
| New | +$5.17M | ﹤0.01% | 4219 |
|
|
2016
Q1 | – | Sell |
-130,000
| Closed | -$382K | – | 6791 |
|
|
2015
Q4 | $382K | Hold |
130,000
| – | – | ﹤0.01% | 4068 |
|
|
2015
Q3 | $1.8M | Hold |
130,000
| – | – | ﹤0.01% | 3076 |
|
|
2015
Q2 | $1.39M | Sell |
130,000
-7,600
| -6% | -$869K | ﹤0.01% | 3347 |
|
|
2015
Q1 | $94K | Buy |
137,600
+129,900
| +1,687% | +$15.5M | ﹤0.01% | 4767 |
|
|
2014
Q4 | $35K | Hold |
7,700
| – | – | ﹤0.01% | 5165 |
|
|
2014
Q3 | $84K | Buy |
+7,700
| New | +$695K | ﹤0.01% | 4733 |
|
|
2014
Q2 | – | Sell |
-200
| Closed | -$4K | – | 6610 |
|
|
2014
Q1 | $4K | Buy |
+200
| New | +$15.8K | ﹤0.01% | 5613 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Wells Fargo's CELG Position: Q4 2019 in Review
Wells Fargo sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,143,828 shares — an estimated $213M sold.
Wells Fargo first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.08B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Wells Fargo reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Wells Fargo sold 2,143,828 Celgene Corp shares in Q4 2019, an estimated $213M.
- Wells Fargo first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Wells Fargo's Celgene Corp position peaked at $1.08B in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Wells Fargo's 13F filing for Q4 2019, filed 14 Feb 2020.